Leiyunshang Pharmaceutical Group

Founded in 1734, Lei Yunshang Pharmaceutical Group has a rich heritage in traditional Chinese medicine. Its founder, Lei Da Sheng (courtesy name Yun Shang, 1696-1779), was a distinguished physician during the Qing dynasty. For nearly 300 years, Lei Yunshang has upheld its founding principles of selecting authentic medicinal ingredients and meticulously crafting premium treatments. Dedicated to both heritage preservation and innovation, the company continues to delve into the essence of traditional Chinese medicine, advancing its practices for modern needs.

Leiyunshang Pharmaceutical Group Co., Ltd. (“Leiyunshang Group”), headquartered in Suzhou, China, is one of China’s four major traditional pharmaceutical houses. It is a nationally recognized time-honored brand, as well as the holder of nationally classified confidential projects and national intangible cultural heritage. Rooted in traditional Chinese medicine (TCM), Leiyunshang Group inherits and advances the essence of the Warm Disease Theory, while actively integrating modern scientific and technological achievements to accelerate its transformation into a science-driven, innovation-oriented modern TCM enterprise. Today, Leiyunshang Group has evolved into a comprehensive TCM and healthcare industry cluster integrating R&D, manufacturing, commercialization, pharmacy chains, wellness services, TCM clinics, and herbal medicine cultivation bases. Guided by its mission of “Gathering a Hundred Herbs to Benefit All People”, Leiyunshang Group upholds the brand philosophy of “300 Years of Leiyunshang, Inheriting the Wisdom of Health”, and remains committed to its founding principle: “Selecting authentic medicinal materials with integrity, and dedicating ourselves to crafting superior pills, powders, ointments, and elixirs.” Through a combination of organic growth and strategic expansion, Leiyunshang Group has continuously strengthened its industrial competitiveness and now operates 13 subsidiaries and affiliated enterprises across Suzhou, Anhui, Beijing, Guangdong, Changchun, Shenyang, Yunnan, and Shaanxi. Focusing on its strengths in Chinese patent medicines, Leiyunshang Group concentrates on major disease areas, cultivates flagship products, and has established a diversified and comprehensive product pipeline spanning multiple key therapeutic fields.

We specialize in cardiovascular, respiratory, urology, oncology, orthopedics, gastroenterology, and metabolic health. Our portfolio features a range of acclaimed traditional Chinese medicines, including Liushen Pills for throat care, the classical prescription Suhexiang Pills, the nationally designated Jianyanling Capsules, Compound Congrong Yizhi Capsules derived from Academician Wang Yongyan’s clinical experience, Qianggu Capsules based on natural medicinal ingredients, the “pharmaceutical pacemaker” Lingbao Heart-Protecting Pills, as well as Angong Niuhuang Pills, Kuhuang Injection/Granules, Bufei Huoxue Capsules, Qingke Pingchuan Granules, Shuangdan Mingmu Capsules, the Nao’an series, Xiaozheng Pills, Pediatric Guangpu Antidiarrheal Oral Liquid, Shenshuaining Capsules, Xueniao’an, Zhishe Tongluo Capsules, Yangyin Shengxue, Zaizao Shengxue, Antike, and the Brucea Javanica Oil product series, among others. As the flagship product of Leiyunshang, Liushen Pills were first documented in the ancient medical text Throat Medicine Essentials (Houke Xinfa) in 1847, with its formula and manufacturing process classified as a a state-level confidential program. These products reflect our commitment to combining heritage with innovation to enhance patient care.

Quality is at the heart of our commitment. We have established nearly a hundred herbal medicine cultivation bases, adhering to strict management standards to ensure quality control from the source. We rigorously manage the entire production process to guarantee product safety and efficacy. Additionally, we have implemented a comprehensive traceability system across the supply chain, enabling full transparency of product and raw material origins, traceability of destinations, verifiable quality, and accountable responsibility.